Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)

Quintero-Vega et al., NCT04425837, PLASMA COVID-19, NCT04425837, Feb 2021
Estimated 236 patient convalescent plasma late treatment RCT with results not reported over 5 years after estimated completion.
29 convalescent plasma RCTs have results missing long after expected1-29
The trials report a total of 3,534 patients, with 15 trials having actual enrollment of 1,143, and the remainder estimated.
Quintero-Vega et al., 1 Feb 2021, Single Blind Randomized Controlled Trial, Colombia, trial NCT04425837 (history) (PLASMA COVID-19). Contact: quiquequintero@yahoo.com.mx, jose.delahoz@fsfb.org.co.
Late treatment
is less effective